Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|November 30, 2002
The alpha v integrin antagonists as novel anticancer agents: an updateJanet S Kerr, Andrew M Slee, Shaker A MousaBirth Defects Research. Part B, Developmental and Reproductive Toxicology|February 13, 2007
Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbitsL David Wise, Katie J Turner, Janet S KerrAnticancer Research|April 9, 2005
Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonistShaker A Mousa, Seema Mohamed, Eric J Wexler, et al.Birth Defects Research. Part B, Developmental and Reproductive Toxicology|December 20, 2007
Assessment of female and male fertility in Sprague-Dawley rats administered vorinostat, a histone deacetylase inhibitorL David Wise, Stan Spence, Louise P Saldutti, et al.International Journal of Toxicology|November 12, 2009
Nonclinical safety assessment of the histone deacetylase inhibitor vorinostatJanet S Kerr, Sheila Galloway, Armando Lagrutta, et al.Journal of Neuroscience Methods|December 14, 2001
An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and ratEric J Wexler, Elaine E Peters, Armando Gonzales, et al.The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
Antisense oligonucleotides selectively regulate aspartyl beta-hydroxylase and its truncated protein isoform in vitro but distribute poorly into A549 tumors in vivoSiew Peng Ho, Michael S Scully, Candice M Krauthauser, et al.Pageof 1